Humacyte HUMA
NASDAQ HUMA
$0.59 +0.00 (+0.29%)
At close: Nov 11, 2026 · 4:00 PM EST

Humacyte (HUMA) Short-term Investments (2021 - 2026)

Updated

Humacyte (HUMA) recorded Short-term Investments of $2.11 million in Q1 2023, down 73.7% from $8 million a year earlier and unchanged from the prior quarter.

Analysis

Humacyte (HUMA) Short-term Investments (2021 - 2026) Analysis & Trends

Starting with Q4 2021, Humacyte's Short-term Investments history includes 6 quarters.

  • Across earlier years, Short-term Investments came in at $8 million in FY2021.
  • Quarterly Short-term Investments has ranged from $2.11 million in Q4 2022 to $8 million in Q3 2022 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $2.11 million (Q4 2022), $8 million (Q3 2022) and $8 million (Q2 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Humacyte 163.90 Mn -213.24 Mn -401,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 44.56 Mn
Jun 30, 2026 44.56 Mn
Mar 31, 2026 44.56 Mn
Mar 31, 2023 2.11 Mn
Dec 31, 2022 2.11 Mn
Sep 30, 2022 8.00 Mn
Jun 30, 2022 8.00 Mn
Mar 31, 2022 8.00 Mn
Dec 31, 2021 8.00 Mn
API Access

Humacyte Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=HUMA&period=max&api_key=YOUR_API_KEY